S Chandrasekaran Selected Research

S Chandrasekaran Research Topics

2	Type 2 Diabetes Mellitus (MODY) 01/2020 - 01/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2021
1	Opportunistic Infections (Opportunistic Infection) 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2016
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016
1	Liver Diseases (Liver Disease) 01/2016
1	Coinfection 09/2011
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 09/2011
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2011
1	Visceral Leishmaniasis (Kala Azar) 09/2011
1	Leptospirosis 01/2004
1	Diabetes Mellitus 01/2003
1	Halitosis 11/2002
1	Hepatitis B 07/2000
1	Hepatitis 07/2000

2	Biomarkers (Surrogate Marker)IBA 07/2021 - 07/2000
1	Biological ProductsIBA 07/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	CoagulaseIBA 01/2018
1	Oxygen (Dioxygen)IBA 01/2016
1	Triglycerides (Triacylglycerol)IBA 01/2016
1	Rosiglitazone (Avandia)FDA Link 01/2016
1	FructoseIBA 01/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Interleukin-2 (IL2)IBA 09/2011
1	LeptinIBA 09/2011
1	Interleukin-12 (IL 12)IBA 09/2011
1	CytokinesIBA 09/2011
1	Immunoglobulin M (IgM)IBA 01/2004
1	Retinaldehyde (Retinal)IBA 01/2003
1	allylpyrocatecholIBA 11/2002
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2000
1	Hepatitis C AntibodiesIBA 07/2000